OPC.VN OPC Pharmaceutical JSC
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 4.04%
- Fundamental score
- 0.2/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.
Is OPC.VN undervalued?
Graham numberThe Graham number of OPC Pharmaceutical JSC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
OPC Pharmaceutical JSC fundamental analysis
1 of 21 checks passedROE 0/2
ROE cannot be calculated: equity is negative or not reported.
ROA 0/1
Return on assets cannot be compared with the industry.
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Earnings growth cannot be compared with the industry.
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash runway cannot be calculated.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book is negative or not available.
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
OPC Pharmaceutical JSC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About OPC Pharmaceutical JSC
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, hormones, external use, digestion, pain relief, anti-inflammatory, health gifts, and other drugs. It also offers nutritional products for health care, supplem…
Full company profileOPC Pharmaceutical JSC financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
OPC Pharmaceutical JSC annual financial statements (VND; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|
| Cash Flow | |||||
| Operating Cash Flow | 56.1B | 124B | 191B | 197B | - |
| Capital Expenditure | 27.1B | 30.8B | 8.91B | 9.02B | 0.00 |
What these items mean
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
OPC Pharmaceutical JSC dividends
- Dividend yield
- 4.04%
- Forward dividend
- 800.00 VND
- Payout ratio
- -
- Ex-dividend date
- Jul 9, 2026
Last stock split: 117:100 on Jul 9, 2026.
Who owns OPC Pharmaceutical JSC
- Insiders 40.14%
- Institutions 0.00%
- Public & others 59.86%
- Free float 43.6M
OPC Pharmaceutical JSC company profile
- Company name
- OPC Pharmaceutical JSC
- Ticker
- OPC.VN
- ISIN
- VN000000OPC9
- Exchange
- Vietnam Stocks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 863
- Fiscal year end
- December
- Address
- 1017 Hong Bang, Ho Chi Minh City, Vietnam
- Phone
- 84 28 3751 7111
- Website
- opcpharma.com
About OPC Pharmaceutical JSC
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, hormones, external use, digestion, pain relief, anti-inflammatory, health gifts, and other drugs. It also offers nutritional products for health care, supplementing nutrients, nourishing the body, and boosting immunity. In addition, the company manufactures and trades pharmaceuticals, medical supplies, machinery, equipment, chemicals, cosmetics, food, and functional foods; production, trading, processing, import and export of traditional medicine, herbal medicine, medicines of natural origin; real estate business, freight transport, electricity; production and sale of alcoholic beverages, carbonated drinks; and cultivation, harvesting, processing, and trading of medicinal herbs and plants. OPC Pharmaceutical Joint Stock Company was founded in 1977 and is based in Ho Chi Minh City, Vietnam.
OPC Pharmaceutical JSC management
4- Ms. Huong Xuan Thi PhamGeneral Director, CEO & Director
- Ms. Anh Thuy Thi LeDeputy General Director
- Mr. Cuong Duc HaDeputy General Director
- Mr. De The NguyenChief Accountant